Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Apr;103(4):383-391.
doi: 10.1111/cge.14296. Epub 2023 Jan 25.

Imagawa-Matsumoto syndrome: SUZ12-related overgrowth disorder

Affiliations
Review

Imagawa-Matsumoto syndrome: SUZ12-related overgrowth disorder

Eri Imagawa et al. Clin Genet. 2023 Apr.

Abstract

The SUZ12 gene encodes a subunit of polycomb repressive complex 2 (PRC2) that is essential for development by silencing the expression of multiple genes. Germline heterozygous variants in SUZ12 have been found in Imagawa-Matsumoto syndrome (IMMAS) characterized by overgrowth and multiple dysmorphic features. Similarly, both EZH2 and EED also encode a subunit of PRC2 each and their pathogenic variants cause Weaver syndrome and Cohen-Gibson syndrome, respectively. Clinical manifestations of these syndromes significantly overlap, although their different prevalence rates have recently been noted: generalized overgrowth, intellectual disability, scoliosis, and excessive loose skin appear to be less prevalent in IMMAS than in the other two syndromes. We could not determine any apparent genotype-phenotype correlation in IMMAS. The phenotype of neurofibromatosis type 1 arising from NF1 deletion was also shown to be modified by the deletion of SUZ12, 560 kb away. This review deepens our understanding of the clinical and genetic characteristics of IMMAS together with other overgrowth syndromes related to PRC2. We also report on a novel IMMAS patient carrying a splicing variant (c.1023+1G>C) in SUZ12. This patient had a milder phenotype than other previously reported IMMAS cases, with no macrocephaly or overgrowth phenotypes, highlighting the clinical variation in IMMAS.

Keywords: Imagawa-Matsumoto syndrome; SUZ12; overgrowth syndrome; polycomb repressive complex 2.

PubMed Disclaimer

References

REFERENCES

    1. Liu X, Liu X. PRC2, chromatin regulation, and human disease: insights from molecular structure and function. Front Oncol. 2022;12:894585. doi:10.3389/fonc.2022.894585
    1. Guo Y, Zhao S, Wang GG. Polycomb gene silencing mechanisms: PRC2 chromatin targeting, H3K27me3 “Readout,” and phase separation-based compaction. Trends Genet. 2021;37(6):547-565. doi:10.1016/j.tig.2020.12.006
    1. Kouznetsova VL, Tchekanov A, Li X, Yan X, Tsigelny IF. Polycomb repressive 2 complex-molecular mechanisms of function. Protein Sci. 2019;28(8):1387-1399. doi:10.1002/pro.3647
    1. Weaver DD, Graham CB, Thomas IT, Smith DW. A new overgrowth syndrome with accelerated skeletal maturation, unusual facies, and camptodactyly. J Pediatr. 1974;84(4):547-552. doi:10.1016/s0022-3476(74)80675-x
    1. Gibson WT, Hood RL, Zhan SH, et al. Mutations in EZH2 cause Weaver syndrome. Am J Hum Genet. 2012;90(1):110-118. doi:10.1016/j.ajhg.2011.11.018

Publication types

MeSH terms

Substances